glp-1 hair loss from Injections We are seeing increased numbers
Description
10.1016/j.jclinane.2024.111693 [DOI] [PubMed] 18.Jalleh RJ, Plummer MP, Marathe CS, Umapathysivam MM, Quast DR, Rayner CK et al (2024) Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists and tirzepatide
The hair shedding that occurs may be related to a significant and quick weight loss when blood sugar levels improve in people using the drug to treat type 2 diabetes

Patients are encouraged to speak with their provider to determine eligibility

Mounjaro ranked second, prescribed to nearly 1% of adults, followed closely by Wegovy, Zepbound, and Saxenda together at around 0.7%

Dealing with limited overlap in estimation of average treatment effects

This alarming trend has prompted a demand for effective pharmacological treatments